Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer
While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern imaging technologies may have improved detection capability and may have a role in some cases. We performed a systematic review of studies (1...
Uloženo v:
| Vydáno v: | Breast (Edinburgh) Ročník 21; číslo 2; s. 112 - 123 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
Elsevier Ltd
01.04.2012
|
| Témata: | |
| ISSN: | 0960-9776, 1532-3080, 1532-3080 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern imaging technologies may have improved detection capability and may have a role in some cases. We performed a systematic review of studies (1995–2011) evaluating the prevalence of DM and the accuracy of staging imaging for detection of asymptomatic DM. Twenty-two studies reporting on 14,824 BC subjects (median age 53 years) undergoing staging imaging were eligible. Median prevalence of DM was 7.0% (range 1.2–48.8%); prevalence increased with increasing BC stage. Conventional imaging studies had lower DM prevalence than studies of PET(PET/CT). Imaging median sensitivity/specificity respectively were: combined conventional imaging 78.0%/91.4%; bone scintigraphy 98.0%/93.5%; chest X-ray 100%/97.9%; liver ultrasound 100%/96.7%; CT chest/abdomen 100%/93.1%; FDG-PET 100.0%/96.5%; FDG-PET/CT 100%/98.1%. Low prevalence of DM was seen in Stage I–II BC with much higher prevalence in more advanced disease. Accuracy of PET modalities was very high however the high proportion of detected asymptomatic DM partly reflects selection bias. |
|---|---|
| AbstractList | While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern imaging technologies may have improved detection capability and may have a role in some cases. We performed a systematic review of studies (1995-2011) evaluating the prevalence of DM and the accuracy of staging imaging for detection of asymptomatic DM. Twenty-two studies reporting on 14,824 BC subjects (median age 53 years) undergoing staging imaging were eligible. Median prevalence of DM was 7.0% (range 1.2-48.8%); prevalence increased with increasing BC stage. Conventional imaging studies had lower DM prevalence than studies of PET(PET/CT). Imaging median sensitivity/specificity respectively were: combined conventional imaging 78.0%/91.4%; bone scintigraphy 98.0%/93.5%; chest X-ray 100%/97.9%; liver ultrasound 100%/96.7%; CT chest/abdomen 100%/93.1%; FDG-PET 100.0%/96.5%; FDG-PET/CT 100%/98.1%. Low prevalence of DM was seen in Stage I-II BC with much higher prevalence in more advanced disease. Accuracy of PET modalities was very high however the high proportion of detected asymptomatic DM partly reflects selection bias.While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern imaging technologies may have improved detection capability and may have a role in some cases. We performed a systematic review of studies (1995-2011) evaluating the prevalence of DM and the accuracy of staging imaging for detection of asymptomatic DM. Twenty-two studies reporting on 14,824 BC subjects (median age 53 years) undergoing staging imaging were eligible. Median prevalence of DM was 7.0% (range 1.2-48.8%); prevalence increased with increasing BC stage. Conventional imaging studies had lower DM prevalence than studies of PET(PET/CT). Imaging median sensitivity/specificity respectively were: combined conventional imaging 78.0%/91.4%; bone scintigraphy 98.0%/93.5%; chest X-ray 100%/97.9%; liver ultrasound 100%/96.7%; CT chest/abdomen 100%/93.1%; FDG-PET 100.0%/96.5%; FDG-PET/CT 100%/98.1%. Low prevalence of DM was seen in Stage I-II BC with much higher prevalence in more advanced disease. Accuracy of PET modalities was very high however the high proportion of detected asymptomatic DM partly reflects selection bias. While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern imaging technologies may have improved detection capability and may have a role in some cases. We performed a systematic review of studies (1995–2011) evaluating the prevalence of DM and the accuracy of staging imaging for detection of asymptomatic DM. Twenty-two studies reporting on 14,824 BC subjects (median age 53 years) undergoing staging imaging were eligible. Median prevalence of DM was 7.0% (range 1.2–48.8%); prevalence increased with increasing BC stage. Conventional imaging studies had lower DM prevalence than studies of PET(PET/CT). Imaging median sensitivity/specificity respectively were: combined conventional imaging 78.0%/91.4%; bone scintigraphy 98.0%/93.5%; chest X-ray 100%/97.9%; liver ultrasound 100%/96.7%; CT chest/abdomen 100%/93.1%; FDG-PET 100.0%/96.5%; FDG-PET/CT 100%/98.1%. Low prevalence of DM was seen in Stage I–II BC with much higher prevalence in more advanced disease. Accuracy of PET modalities was very high however the high proportion of detected asymptomatic DM partly reflects selection bias. Abstract While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern imaging technologies may have improved detection capability and may have a role in some cases. We performed a systematic review of studies (1995–2011) evaluating the prevalence of DM and the accuracy of staging imaging for detection of asymptomatic DM. Twenty-two studies reporting on 14,824 BC subjects (median age 53 years) undergoing staging imaging were eligible. Median prevalence of DM was 7.0% (range 1.2–48.8%); prevalence increased with increasing BC stage. Conventional imaging studies had lower DM prevalence than studies of PET(PET/CT). Imaging median sensitivity/specificity respectively were: combined conventional imaging 78.0%/91.4%; bone scintigraphy 98.0%/93.5%; chest X-ray 100%/97.9%; liver ultrasound 100%/96.7%; CT chest/abdomen 100%/93.1%; FDG-PET 100.0%/96.5%; FDG-PET/CT 100%/98.1%. Low prevalence of DM was seen in Stage I–II BC with much higher prevalence in more advanced disease. Accuracy of PET modalities was very high however the high proportion of detected asymptomatic DM partly reflects selection bias. |
| Author | Houssami, N. Brennan, M.E. |
| Author_xml | – sequence: 1 givenname: M.E. surname: Brennan fullname: Brennan, M.E. email: meagan.brennan@sydney.edu.au – sequence: 2 givenname: N. surname: Houssami fullname: Houssami, N. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22094116$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVUk2LFDEQDbLizq7-A5HcPPVYSX9GRJBl_YAFD-o5pJPqMWN3MibpkTn5103bux4EWTwFKu-9qnqvLsiZ8w4Jecpgy4A1L_bbPqCKacuBsVzaAtQPyIbVJS9K6OCMbEA0UIi2bc7JRYx7ABBl0z0i55yDqBhrNuTn9VGNs0rWO-oHmr4ixaM16DTSXIpJ7azbUTut7-ADNZhQ3xFUPE2H5KesoKmxGe8SnTDlwVTESK2jDn-Mp_ynds5HNHQdm2qVe4TH5OGgxohPbt9L8uXt9eer98XNx3cfrt7cFLruWCr6uht0q-tBADAUqs2rdbzrNVQKGa-Mabuur4e-r4CL1nBohRoQdNOYuu-H8pI8X3UPwX-fMSY52ahxHJVDP0cpqq4TpRA8I5_dIud-QiMPIS8fTvLOswyoVoAOPsaAwx8IA7lEI_dy3VEu0SzVHE2mvfyLpm36bXwKyo73kV-vZMweHS0GGbVdQjI25DCk8fZ_BfRondVq_IYnjHs_B5f9l0xGLkF-Wk5nuRzGAMqWiyzw6t8C9_f_BVeH2BY |
| CitedBy_id | crossref_primary_10_1080_08998280_2024_2376972 crossref_primary_10_1007_s12282_023_01521_x crossref_primary_10_1186_2193_1801_3_176 crossref_primary_10_1634_theoncologist_2016_0157 crossref_primary_10_1007_s10269_013_2344_4 crossref_primary_10_3389_fonc_2024_1409273 crossref_primary_10_1016_j_ijsu_2017_09_004 crossref_primary_10_1002_cncr_30674 crossref_primary_10_1007_s10549_017_4443_x crossref_primary_10_1016_j_breast_2012_08_001 crossref_primary_10_1097_MNM_0000000000001081 crossref_primary_10_1245_s10434_012_2571_4 crossref_primary_10_1016_j_breast_2014_08_009 crossref_primary_10_1016_j_gyobfe_2013_11_006 crossref_primary_10_1097_RLU_0000000000001165 crossref_primary_10_1007_s12609_018_0268_9 crossref_primary_10_3390_diagnostics11111954 crossref_primary_10_1186_s12957_019_1584_x crossref_primary_10_1016_j_clbc_2021_01_017 crossref_primary_10_1002_jso_24436 crossref_primary_10_1245_s10434_019_07543_0 crossref_primary_10_3892_ijo_2017_4012 crossref_primary_10_1016_j_breast_2017_02_003 crossref_primary_10_1111_tbj_12416 crossref_primary_10_4102_sajo_v4i0_94 crossref_primary_10_1007_s40134_013_0016_x crossref_primary_10_1111_ans_17324 crossref_primary_10_1016_j_clbc_2020_07_004 crossref_primary_10_1016_j_soc_2023_05_008 crossref_primary_10_1371_journal_pone_0246563 crossref_primary_10_1016_j_bulcan_2015_02_018 crossref_primary_10_1055_s_0038_1666997 crossref_primary_10_3390_jcm10050906 crossref_primary_10_1684_bdc_2013_1847 crossref_primary_10_1158_1078_0432_CCR_23_0757 crossref_primary_10_1007_s10549_016_3937_2 crossref_primary_10_1259_bjr_20160809 crossref_primary_10_1007_s00404_024_07753_2 crossref_primary_10_1007_s10549_020_05813_0 crossref_primary_10_1016_j_jss_2015_02_065 crossref_primary_10_1007_s12282_016_0674_7 crossref_primary_10_3892_mco_2021_2436 crossref_primary_10_2217_bmt_12_9 crossref_primary_10_1007_s12282_014_0557_8 crossref_primary_10_1016_j_ejrad_2017_08_018 crossref_primary_10_1007_s10549_016_3687_1 crossref_primary_10_1093_bjsopen_zraa006 crossref_primary_10_1111_ajco_13600 crossref_primary_10_1093_annonc_mdu385 crossref_primary_10_1016_j_jradio_2017_01_009 crossref_primary_10_1177_0300891619882491 crossref_primary_10_1177_000313481908500114 crossref_primary_10_1038_s41598_024_66658_x crossref_primary_10_1007_s12282_014_0542_2 crossref_primary_10_1111_jep_12240 crossref_primary_10_1200_GO_20_00257 crossref_primary_10_1007_s12282_019_01025_7 crossref_primary_10_1016_j_breast_2016_06_017 crossref_primary_10_1186_s13244_020_00885_4 crossref_primary_10_1007_s12149_016_1132_5 crossref_primary_10_1016_j_breast_2012_01_011 crossref_primary_10_1016_j_ejca_2017_08_017 crossref_primary_10_1016_j_clbc_2023_06_008 crossref_primary_10_2217_bmt_12_52 crossref_primary_10_1007_s10269_013_2348_9 crossref_primary_10_3390_medicina60020321 crossref_primary_10_1080_07357907_2018_1564325 |
| Cites_doi | 10.1371/journal.pmed.1000100 10.1002/1097-0142(19880301)61:5<1038::AID-CNCR2820610530>3.0.CO;2-Z 10.3310/hta14500 10.2967/jnumed.108.052050 10.1016/j.jclinepi.2009.02.005 10.1634/theoncologist.2011-0089 10.1001/jama.1994.03510440053032 10.1007/s00259-007-0580-5 10.1002/cncr.24534 10.1200/JCO.2008.17.1496 10.1002/14651858.CD001768.pub2 10.6004/jnccn.2011.0016 10.1093/annonc/mdi063 10.1038/sj.bjc.6605323 10.1001/jama.1994.03510440047031 10.1007/BF02944350 10.1002/cncr.21200 10.1200/JCO.2004.07.058 10.1007/s002590000448 10.1016/j.ijrobp.2008.02.056 10.1111/j.1524-4741.2010.00987.x 10.1023/A:1014900600815 10.1007/BF02985050 10.1007/s10549-011-1368-7 10.1089/cbr.2007.358 10.1111/j.1075-122X.2005.21625.x 10.1111/j.1524-4741.2006.00343.x 10.1023/A:1008483806113 10.1093/jjco/hye049 10.2967/jnumed.108.056010 |
| ContentType | Journal Article |
| Copyright | 2011 Elsevier Ltd Elsevier Ltd Copyright © 2011 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.breast.2011.10.005 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-3080 |
| EndPage | 123 |
| ExternalDocumentID | 22094116 10_1016_j_breast_2011_10_005 S0960977611003729 1_s2_0_S0960977611003729 |
| Genre | Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPKN AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HEC HMK HMO HVGLF HZ~ IHE J1W KOM L7B M29 M2X M41 MO0 N9A O-L O9- OAUVE OC~ OK1 OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPM RPZ SAE SCC SDF SDG SDP SEL SES SEW SSH SSZ T5K WUQ Z5R ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG 6I. AAFTH AAIAV ABLVK ABYKQ AJBFU LCYCR NCXOZ 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c581t-b58fc7c5f9001e9a7096828bc04ae124dd788b5fbb40297d2079afe0c66d5bbf3 |
| ISICitedReferencesCount | 94 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000302841000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0960-9776 1532-3080 |
| IngestDate | Thu Oct 02 10:17:56 EDT 2025 Mon Jul 21 05:31:27 EDT 2025 Tue Nov 18 20:57:58 EST 2025 Sat Nov 29 07:05:49 EST 2025 Fri Feb 23 02:33:49 EST 2024 Sun Feb 23 10:18:52 EST 2025 Tue Oct 14 19:33:55 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Sensitivity and specificity Breast cancer Distant metastases Staging Imaging |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 Copyright © 2011 Elsevier Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c581t-b58fc7c5f9001e9a7096828bc04ae124dd788b5fbb40297d2079afe0c66d5bbf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.breast.2011.10.005 |
| PMID | 22094116 |
| PQID | 948893992 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_948893992 pubmed_primary_22094116 crossref_primary_10_1016_j_breast_2011_10_005 crossref_citationtrail_10_1016_j_breast_2011_10_005 elsevier_sciencedirect_doi_10_1016_j_breast_2011_10_005 elsevier_clinicalkeyesjournals_1_s2_0_S0960977611003729 elsevier_clinicalkey_doi_10_1016_j_breast_2011_10_005 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-04-01 |
| PublicationDateYYYYMMDD | 2012-04-01 |
| PublicationDate_xml | – month: 04 year: 2012 text: 2012-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Breast (Edinburgh) |
| PublicationTitleAlternate | Breast |
| PublicationYear | 2012 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | The GIVIO Investigators (bib36) 1994; 271 van der Hoeven (bib29) 2004; 22 Kasem, Desai, Daniell, Sinha (bib20) 2006; 12 National Breast Cancer Centre (NBCC) (bib2) 2001 Abe, Sasaki, Kuwabara, Koga, Baba, Hayashi (bib9) 2005; 19 SAS Version 9.2. NC, USA. Kim, Han, Moon, Min, Ahn, Kim (bib21) 2011; 126 Reitsma, Rutjes, Khan, Coomarasamy, Bossuyt (bib33) 2009; 62 Liberati, Altman, Tetzlaff, Mulrow, G√∏tzsche, Ioannidis (bib8) 2009; 6 Ciatto, Pacini, Azzini, Neri, Jannini, Gosso (bib5) 1988; 61 Carlson, Allred, Anderson, Burstein, Carter, Edge (bib1) 2011; 9 Ravaioli, Tassinari, Pasini, Polselli, Papi, Fattori (bib26) 1998; 9 Koizumi, Yoshimoto, Kasumi, Ogata (bib22) 2001; 31 Lee, Park, Han, Kim, Shin, Choe (bib23) 2005; 104 Buchmann, Riedmüller, Hoffner, Mack, Aulmann, Haberkorn (bib13) 2007; 22 Carkaci, Macapinlac, Cristofanilli, Mawlawi, Rohren, Gonzalez Angulo (bib14) 2009; 50 Niikura, Costelloe, Madewell, Hayashi, Yu, Liu (bib24) 2011; 16 Weir, Worsley, Bernstein (bib30) 2005; 11 Schirrmeister, Kühn, Guhlmann, Santjohanser, Hörster, Nüssle (bib27) 2001; 28 Houssami, Costelloe (bib31) 2011 Barry, Thornton, Murphy, Younis, Watson (bib12) 1999; 168 Fuster, Duch, Paredes, Velasco, Munoz, Santamaria (bib17) 2008; 26 Dillman, Chico (bib16) 2000; 3 Rojas, Telaro, Russo, Moschetti, Coe, Fossati (bib34) 2000 Heusner, Kuemmel, Umutlu, Koeninger, Freudenberg, Hauth (bib19) 2008; 49 Alberini, Lerebours, Wartski, Fourme, Le Stanc, Gontier (bib10) 2009; 115 Scottish Intercollegiate Guidelines Network (bib3) 2005 Ravaioli, Pasini, Polselli, Papi, Tassinari, Arcangeli (bib6) 2002; 72 Segaert, Mottaghy, Ceyssens, De Wever, Stroobants, Van Ongeval (bib28) 2010; 16 Barrett, Bowden, Greenberg, Brown, Wishart, Britton (bib11) 2009; 101 Çermik, Mavi, Basu, Alavi (bib15) 2008; 35 Puglisi, Follador, Minisini, Cardellino, Russo, Andreetta (bib25) 2005; 16 Roselli del Turco, Palli, Cariddi, Ciatto, Pacini, Distante (bib35) 1994; 271 Groheux, Moretti, Baillet, Espie, Giacchetti, Hindie (bib18) 2008; 71 Pennant, Takwoingi, Pennant, Davenport, Fry-Smith, Eisinga (bib32) 2010; 14 Cancer Care Ontario (bib4) 2003 Kim (10.1016/j.breast.2011.10.005_bib21) 2011; 126 Niikura (10.1016/j.breast.2011.10.005_bib24) 2011; 16 National Breast Cancer Centre (NBCC) (10.1016/j.breast.2011.10.005_bib2) 2001 Buchmann (10.1016/j.breast.2011.10.005_bib13) 2007; 22 Çermik (10.1016/j.breast.2011.10.005_bib15) 2008; 35 Barrett (10.1016/j.breast.2011.10.005_bib11) 2009; 101 Kasem (10.1016/j.breast.2011.10.005_bib20) 2006; 12 Pennant (10.1016/j.breast.2011.10.005_bib32) 2010; 14 Segaert (10.1016/j.breast.2011.10.005_bib28) 2010; 16 Ciatto (10.1016/j.breast.2011.10.005_bib5) 1988; 61 Rojas (10.1016/j.breast.2011.10.005_bib34) 2000 Puglisi (10.1016/j.breast.2011.10.005_bib25) 2005; 16 Ravaioli (10.1016/j.breast.2011.10.005_bib26) 1998; 9 Roselli del Turco (10.1016/j.breast.2011.10.005_bib35) 1994; 271 Carlson (10.1016/j.breast.2011.10.005_bib1) 2011; 9 Abe (10.1016/j.breast.2011.10.005_bib9) 2005; 19 Reitsma (10.1016/j.breast.2011.10.005_bib33) 2009; 62 Houssami (10.1016/j.breast.2011.10.005_bib31) 2011 10.1016/j.breast.2011.10.005_bib7 Lee (10.1016/j.breast.2011.10.005_bib23) 2005; 104 Fuster (10.1016/j.breast.2011.10.005_bib17) 2008; 26 Barry (10.1016/j.breast.2011.10.005_bib12) 1999; 168 Scottish Intercollegiate Guidelines Network (10.1016/j.breast.2011.10.005_bib3) 2005 Liberati (10.1016/j.breast.2011.10.005_bib8) 2009; 6 Dillman (10.1016/j.breast.2011.10.005_bib16) 2000; 3 Schirrmeister (10.1016/j.breast.2011.10.005_bib27) 2001; 28 The GIVIO Investigators (10.1016/j.breast.2011.10.005_bib36) 1994; 271 Alberini (10.1016/j.breast.2011.10.005_bib10) 2009; 115 Weir (10.1016/j.breast.2011.10.005_bib30) 2005; 11 Cancer Care Ontario (10.1016/j.breast.2011.10.005_bib4) 2003 Groheux (10.1016/j.breast.2011.10.005_bib18) 2008; 71 Heusner (10.1016/j.breast.2011.10.005_bib19) 2008; 49 van der Hoeven (10.1016/j.breast.2011.10.005_bib29) 2004; 22 Koizumi (10.1016/j.breast.2011.10.005_bib22) 2001; 31 Ravaioli (10.1016/j.breast.2011.10.005_bib6) 2002; 72 Carkaci (10.1016/j.breast.2011.10.005_bib14) 2009; 50 |
| References_xml | – reference: SAS Version 9.2. NC, USA. – volume: 271 start-page: 1587 year: 1994 end-page: 1592 ident: bib36 article-title: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial publication-title: JAMA – volume: 12 start-page: 544 year: 2006 end-page: 548 ident: bib20 article-title: Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer publication-title: The Breast Journal – volume: 14 start-page: 1 year: 2010 end-page: 103 ident: bib32 article-title: A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence publication-title: Health Technol Assess – volume: 126 start-page: 637 year: 2011 end-page: 641 ident: bib21 article-title: The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma publication-title: Breast Cancer Research and Treatment – volume: 101 start-page: 1522 year: 2009 end-page: 1528 ident: bib11 article-title: Radiological staging in breast cancer: Which asymptomatic patients to image and how publication-title: British Journal of Cancer – volume: 115 start-page: 5038 year: 2009 end-page: 5047 ident: bib10 article-title: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer publication-title: Cancer – volume: 31 start-page: 263 year: 2001 end-page: 269 ident: bib22 article-title: What do breast cancer patients benefit from staging bone scintigraphy? publication-title: Japanese Journal of Clinical Oncology – volume: 28 start-page: 351 year: 2001 end-page: 358 ident: bib27 article-title: Fluorine-18 2-deoxy-2-fluoro-d-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures publication-title: European Journal of Nuclear Medicine and Molecular Imaging – volume: 72 start-page: 53 year: 2002 end-page: 60 ident: bib6 article-title: Staging of breast cancer: new recommended standard procedure publication-title: Breast Cancer Research and Treatment – volume: 11 start-page: 204 year: 2005 end-page: 209 ident: bib30 article-title: The value of FDG positron emission tomography in the management of patients with breast cancer publication-title: The Breast Journal – volume: 9 start-page: 1173 year: 1998 end-page: 1177 ident: bib26 article-title: Staging of breast cancer: what standards should be used in research and clinical practice? publication-title: Annals of Oncology – year: 2003 ident: bib4 article-title: Baseline staging tests in primary breast cancer practice guideline report # 1–14 – volume: 19 start-page: 573 year: 2005 end-page: 579 ident: bib9 article-title: Comparison of FDG-PET with TC-HMDP scntigraphy for the detection of bone metastases in patients with breast cancer publication-title: Annals of Nuclear Medicine – volume: 35 start-page: 475 year: 2008 end-page: 483 ident: bib15 article-title: Impact of fdg pet on the preoperative staging of newly diagnosed breast cancer publication-title: European Journal of Nuclear Medicine and Molecular Imaging – volume: 16 start-page: 1111 year: 2011 end-page: 1119 ident: bib24 article-title: FDG-PET/CT Compared with conventional imaging in the Detection of distant metastases of primary breast cancer publication-title: The Oncologist – volume: 16 start-page: 617 year: 2010 end-page: 624 ident: bib28 article-title: Additional value of PET–CT in staging of clinical stage IIB and III breast cancer publication-title: The Breast Journal – volume: 61 start-page: 1038 year: 1988 end-page: 1040 ident: bib5 article-title: Preoperative staging of primary breast cancer. A multicentric study publication-title: Cancer – volume: 26 start-page: 4746 year: 2008 end-page: 4751 ident: bib17 article-title: Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures publication-title: Journal of Clinical Oncology – volume: 49 start-page: 1215 year: 2008 end-page: 1222 ident: bib19 article-title: Breast cancer staging in a single session: whole-body PET/CT mammography publication-title: Journal of Nuclear Medicine – year: 2011 ident: bib31 article-title: Imaging bone metastases in breast cancer: evidence on comparative test accuracy publication-title: Annals of Oncology – volume: 16 start-page: 263 year: 2005 end-page: 266 ident: bib25 article-title: Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications publication-title: Annals of Oncology – volume: 62 start-page: 797 year: 2009 end-page: 806 ident: bib33 article-title: A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard publication-title: Journal of Clinical Epidemiology – volume: 9 start-page: 136 year: 2011 end-page: 222 ident: bib1 article-title: Invasive breast cancer: NCCN clinical practice guidelines in oncology publication-title: Journal of the National Comprehensive Cancer Network – volume: 168 start-page: 248 year: 1999 end-page: 250 ident: bib12 article-title: The value of metastatic screening in early primary breast cancer publication-title: Irish Journal of Medical Science – volume: 71 start-page: 695 year: 2008 end-page: 704 ident: bib18 article-title: Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer publication-title: International Journal of Radiation Oncology Biology Physics – year: 2005 ident: bib3 article-title: Management of breast cancer in women – a national clinical guideline – volume: 104 start-page: 499 year: 2005 end-page: 503 ident: bib23 article-title: The clinical use of staging bone scan in patients with breast carcinoma publication-title: Cancer – volume: 50 start-page: 231 year: 2009 end-page: 238 ident: bib14 article-title: Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data publication-title: Journal of Nuclear Medicine – year: 2000 ident: bib34 article-title: Follow-up strategies for women treated for early breast cancer publication-title: Cochrane Database Systematic Reviews – volume: 22 start-page: 1253 year: 2004 end-page: 1259 ident: bib29 article-title: 18F-2-fluoro-2-deoxy- publication-title: Journal of Clinical Oncology – volume: 271 start-page: 1593 year: 1994 end-page: 1597 ident: bib35 article-title: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up publication-title: JAMA – volume: 6 start-page: e1000100 year: 2009 ident: bib8 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: PLoS Med – volume: 3 start-page: 1 year: 2000 end-page: 6 ident: bib16 article-title: Radiologic tests after a new diagnosis of breast cancer publication-title: Effective Clinical Practice – volume: 22 start-page: 779 year: 2007 end-page: 789 ident: bib13 article-title: Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer publication-title: Cancer Biotherapy & Radiopharmaceuticals – year: 2001 ident: bib2 article-title: Clinical practice guidelines for the management of early breast cancer – volume: 6 start-page: e1000100 issue: 7 year: 2009 ident: 10.1016/j.breast.2011.10.005_bib8 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: PLoS Med doi: 10.1371/journal.pmed.1000100 – volume: 61 start-page: 1038 issue: 5 year: 1988 ident: 10.1016/j.breast.2011.10.005_bib5 article-title: Preoperative staging of primary breast cancer. A multicentric study publication-title: Cancer doi: 10.1002/1097-0142(19880301)61:5<1038::AID-CNCR2820610530>3.0.CO;2-Z – volume: 14 start-page: 1 issue: 50 year: 2010 ident: 10.1016/j.breast.2011.10.005_bib32 article-title: A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence publication-title: Health Technol Assess doi: 10.3310/hta14500 – volume: 49 start-page: 1215 year: 2008 ident: 10.1016/j.breast.2011.10.005_bib19 article-title: Breast cancer staging in a single session: whole-body PET/CT mammography publication-title: Journal of Nuclear Medicine doi: 10.2967/jnumed.108.052050 – volume: 62 start-page: 797 year: 2009 ident: 10.1016/j.breast.2011.10.005_bib33 article-title: A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard publication-title: Journal of Clinical Epidemiology doi: 10.1016/j.jclinepi.2009.02.005 – volume: 16 start-page: 1111 issue: 8 year: 2011 ident: 10.1016/j.breast.2011.10.005_bib24 article-title: FDG-PET/CT Compared with conventional imaging in the Detection of distant metastases of primary breast cancer publication-title: The Oncologist doi: 10.1634/theoncologist.2011-0089 – volume: 271 start-page: 1593 issue: 20 year: 1994 ident: 10.1016/j.breast.2011.10.005_bib35 article-title: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up publication-title: JAMA doi: 10.1001/jama.1994.03510440053032 – volume: 35 start-page: 475 issue: 3 year: 2008 ident: 10.1016/j.breast.2011.10.005_bib15 article-title: Impact of fdg pet on the preoperative staging of newly diagnosed breast cancer publication-title: European Journal of Nuclear Medicine and Molecular Imaging doi: 10.1007/s00259-007-0580-5 – year: 2011 ident: 10.1016/j.breast.2011.10.005_bib31 article-title: Imaging bone metastases in breast cancer: evidence on comparative test accuracy publication-title: Annals of Oncology – volume: 115 start-page: 5038 issue: 21 year: 2009 ident: 10.1016/j.breast.2011.10.005_bib10 article-title: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer publication-title: Cancer doi: 10.1002/cncr.24534 – volume: 26 start-page: 4746 issue: 29 year: 2008 ident: 10.1016/j.breast.2011.10.005_bib17 article-title: Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2008.17.1496 – issue: 4 year: 2000 ident: 10.1016/j.breast.2011.10.005_bib34 article-title: Follow-up strategies for women treated for early breast cancer publication-title: Cochrane Database Systematic Reviews doi: 10.1002/14651858.CD001768.pub2 – volume: 9 start-page: 136 issue: 2 year: 2011 ident: 10.1016/j.breast.2011.10.005_bib1 article-title: Invasive breast cancer: NCCN clinical practice guidelines in oncology publication-title: Journal of the National Comprehensive Cancer Network doi: 10.6004/jnccn.2011.0016 – volume: 16 start-page: 263 issue: 2 year: 2005 ident: 10.1016/j.breast.2011.10.005_bib25 article-title: Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications publication-title: Annals of Oncology doi: 10.1093/annonc/mdi063 – volume: 101 start-page: 1522 year: 2009 ident: 10.1016/j.breast.2011.10.005_bib11 article-title: Radiological staging in breast cancer: Which asymptomatic patients to image and how publication-title: British Journal of Cancer doi: 10.1038/sj.bjc.6605323 – volume: 271 start-page: 1587 issue: 20 year: 1994 ident: 10.1016/j.breast.2011.10.005_bib36 article-title: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial publication-title: JAMA doi: 10.1001/jama.1994.03510440047031 – year: 2005 ident: 10.1016/j.breast.2011.10.005_bib3 – volume: 168 start-page: 248 issue: 4 year: 1999 ident: 10.1016/j.breast.2011.10.005_bib12 article-title: The value of metastatic screening in early primary breast cancer publication-title: Irish Journal of Medical Science doi: 10.1007/BF02944350 – volume: 104 start-page: 499 year: 2005 ident: 10.1016/j.breast.2011.10.005_bib23 article-title: The clinical use of staging bone scan in patients with breast carcinoma publication-title: Cancer doi: 10.1002/cncr.21200 – volume: 22 start-page: 1253 issue: 7 year: 2004 ident: 10.1016/j.breast.2011.10.005_bib29 article-title: 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2004.07.058 – volume: 28 start-page: 351 issue: 3 year: 2001 ident: 10.1016/j.breast.2011.10.005_bib27 article-title: Fluorine-18 2-deoxy-2-fluoro-d-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures publication-title: European Journal of Nuclear Medicine and Molecular Imaging doi: 10.1007/s002590000448 – ident: 10.1016/j.breast.2011.10.005_bib7 – volume: 71 start-page: 695 issue: 3 year: 2008 ident: 10.1016/j.breast.2011.10.005_bib18 article-title: Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer publication-title: International Journal of Radiation Oncology Biology Physics doi: 10.1016/j.ijrobp.2008.02.056 – volume: 3 start-page: 1 issue: 1 year: 2000 ident: 10.1016/j.breast.2011.10.005_bib16 article-title: Radiologic tests after a new diagnosis of breast cancer publication-title: Effective Clinical Practice – year: 2001 ident: 10.1016/j.breast.2011.10.005_bib2 – volume: 16 start-page: 617 issue: 6 year: 2010 ident: 10.1016/j.breast.2011.10.005_bib28 article-title: Additional value of PET–CT in staging of clinical stage IIB and III breast cancer publication-title: The Breast Journal doi: 10.1111/j.1524-4741.2010.00987.x – year: 2003 ident: 10.1016/j.breast.2011.10.005_bib4 – volume: 72 start-page: 53 issue: 1 year: 2002 ident: 10.1016/j.breast.2011.10.005_bib6 article-title: Staging of breast cancer: new recommended standard procedure publication-title: Breast Cancer Research and Treatment doi: 10.1023/A:1014900600815 – volume: 19 start-page: 573 issue: 7 year: 2005 ident: 10.1016/j.breast.2011.10.005_bib9 article-title: Comparison of FDG-PET with TC-HMDP scntigraphy for the detection of bone metastases in patients with breast cancer publication-title: Annals of Nuclear Medicine doi: 10.1007/BF02985050 – volume: 126 start-page: 637 issue: 3 year: 2011 ident: 10.1016/j.breast.2011.10.005_bib21 article-title: The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma publication-title: Breast Cancer Research and Treatment doi: 10.1007/s10549-011-1368-7 – volume: 22 start-page: 779 issue: 6 year: 2007 ident: 10.1016/j.breast.2011.10.005_bib13 article-title: Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer publication-title: Cancer Biotherapy & Radiopharmaceuticals doi: 10.1089/cbr.2007.358 – volume: 11 start-page: 204 issue: 3 year: 2005 ident: 10.1016/j.breast.2011.10.005_bib30 article-title: The value of FDG positron emission tomography in the management of patients with breast cancer publication-title: The Breast Journal doi: 10.1111/j.1075-122X.2005.21625.x – volume: 12 start-page: 544 issue: 6 year: 2006 ident: 10.1016/j.breast.2011.10.005_bib20 article-title: Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer publication-title: The Breast Journal doi: 10.1111/j.1524-4741.2006.00343.x – volume: 9 start-page: 1173 issue: 11 year: 1998 ident: 10.1016/j.breast.2011.10.005_bib26 article-title: Staging of breast cancer: what standards should be used in research and clinical practice? publication-title: Annals of Oncology doi: 10.1023/A:1008483806113 – volume: 31 start-page: 263 issue: 6 year: 2001 ident: 10.1016/j.breast.2011.10.005_bib22 article-title: What do breast cancer patients benefit from staging bone scintigraphy? publication-title: Japanese Journal of Clinical Oncology doi: 10.1093/jjco/hye049 – volume: 50 start-page: 231 year: 2009 ident: 10.1016/j.breast.2011.10.005_bib14 article-title: Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data publication-title: Journal of Nuclear Medicine doi: 10.2967/jnumed.108.056010 |
| SSID | ssj0009368 |
| Score | 2.3177273 |
| SecondaryResourceType | review_article |
| Snippet | While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer (BC), modern... Abstract While guidelines recommend against routine use of staging imaging to detect asymptomatic distant metastases (DM) in newly diagnosed breast cancer... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 112 |
| SubjectTerms | Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - pathology Diagnostic Imaging - methods Distant metastases Female Hematology, Oncology and Palliative Medicine Humans Imaging Neoplasm Metastasis - diagnosis Neoplasm Metastasis - pathology Neoplasm Staging Sensitivity and specificity Staging |
| Title | Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0960977611003729 https://www.clinicalkey.es/playcontent/1-s2.0-S0960977611003729 https://dx.doi.org/10.1016/j.breast.2011.10.005 https://www.ncbi.nlm.nih.gov/pubmed/22094116 https://www.proquest.com/docview/948893992 |
| Volume | 21 |
| WOSCitedRecordID | wos000302841000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-3080 dateEnd: 20130630 omitProxy: false ssIdentifier: ssj0009368 issn: 0960-9776 databaseCode: AIEXJ dateStart: 20090601 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Na9swFBdrOsYuY59d9lF0GLu52EpsWccyUrrRZoOlkJuQJRlSGier3dGe9q_vPUuyA21Jd9jFEXKebfn9LD3p_fQeIZ-EUEnJmI2MiW00TksT5cqIqFRjNYJSmWrdJpvg02k-n4sfflWpbtMJ8KrKr6_F-r-qGupA2bh19h_U3V0UKqAMSocjqB2OD1L8pIvfHfz_1mcORccAGINtWqLF0v0iy9DYxuogoOqb5bpZuUiuBq3LqsE80wpKdcvewizkFze4aoskPbRgkdjeIH9Me65vFzGpPQFG7ASGSO_Q6VYe4GzlsyOf9hsijldXda2Wi95N5NckkNzRUVlCN8qiUexyNB3YO-p838uSDYyxjY40ceTqWx28W2s4P3AtcyFYW3Ze2g9owYk__S6Pzk5O5Gwyn31e_4ow1Ri65H3elR2yy3gq8gHZPfw6mX_rYzWP3A7K8MBhx2VLC7x94_ssmvtmLK3lMntOnvkpBz10UHlBHtnqJXly6kkVr8ifHjF0VVJADA2IoVDlEUM9YigghnaIQYFNxFCPGNojhi4q2iKGdoihrnnUIeY1OTuazL4cRz4vR6TTPGmiIs1LzXVaCrBxrFAcpsEwcS90PFYW7EVjeJ4XaVkUY0yNZljMhSptrLPMpEVRjt6QQbWq7FtClRLMsIwpbfJxYmMVa3jjcEmY6GaaF0MyCu9Wah-0HnOnXMjATjyX7pElagRrQSNDEnVSaxe0Zcv_06A2GTYkwxAqAXRb5Phdcrb23UEtE1kzGcufbWBHzjMM0IiO8k1Jb-o6E_YB96QBVxJGAnTvqcrCpykFjMUC40wPyZ7DW9d4xmIxTpLs3Xbh9-Rp_0V_IIPm8sp-JI_172ZRX-6THT7P9_0H8xeUaeN5 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+evidence+on+staging+imaging+for+detection+of+asymptomatic+distant+metastases+in+newly+diagnosed+breast+cancer&rft.jtitle=Breast+%28Edinburgh%29&rft.au=Brennan%2C+M+E&rft.au=Houssami%2C+N&rft.date=2012-04-01&rft.issn=1532-3080&rft.eissn=1532-3080&rft.volume=21&rft.issue=2&rft.spage=112&rft_id=info:doi/10.1016%2Fj.breast.2011.10.005&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09609776%2FS0960977612X0002X%2Fcov150h.gif |